DUNEDIN, New Zealand – Cancer diagnostics company Pacific Edge (NZX, ASX: PEB) releases its investor update for the three months to the end of December 2025 (Q3 26) today with reports on further strategic achievements to support a reinstatement of M

Fletcher Building today announced that it has entered into a binding agreement to sell its Construction Division to major international construction group VINCI Construction (VINCI) for $315.6 million

It’s a brand new year and we’re starting it filled with optimism, momentum and a deep sense of gratitude to you - a very special supporter of Stuff Group

Fisher & Paykel Healthcare appoints Anna Curzon to the Board as a non-executive director; appoints Margie Apa as new Future Director participant

Winton's interim results for FY26 will be announced before NZX trading begins on Friday 20 February 2026

What does this mean for the outlook for the New Zealand and Australian stock markets?

If you have listed NZX and ASX investments and you are in the process of reassessing your holdings or wish to do so, our advisers at Equity Investment Advisers Limited are willing to assist. As you are no doubt aware most markets are fully priced, and som